University of Chicago [clinicaltrials_resource:62f4153f5eb867c0d7e29607386bc8cd]
Michael Maitland, M.D. [clinicaltrials_resource:00d3475a545383ae19aa6e05d5f5159a]Jon Grant, MD,JD,MPH [clinicaltrials_resource:0191670599e4edee8ee40047c3983e17]Tammy Utset, MD [clinicaltrials_resource:01dbc053bfbebeb2e158cc958821a62d]Everett Vokes, M.D. [clinicaltrials_resource:01f8f5dd26d3794e7de5fb88a9d82722]Valerie G Press, MD, MPH [clinicaltrials_resource:023ae2e65af081b733fa909ac65b579c]John P Kress, MD [clinicaltrials_resource:026cf7cc1fd18385cf25b71a2ec86bd1]Leila Gozal, MD [clinicaltrials_resource:02b3877f5d26e601d6264d1aac39b36b]Jay L Koyner, MD [clinicaltrials_resource:030032e458125e38df91b2fc0c713bfd]David Meltzer, M.D., Ph.D. [clinicaltrials_resource:032fd9f39b6b139c4dd1acf290a98aab]Antonio Pellicer, MDPhD [clinicaltrials_resource:04d4442faff5f7e35e194ccdd801cc11]Mitchell C. Posner, MD [clinicaltrials_resource:04fa15921bcf31f1c076ac84e8b04717]Olufunmilayo I Olopade, MD [clinicaltrials_resource:05e3d2f5f7ce5364b4f653f8cbe1642a]Joel Pekow, M.D. [clinicaltrials_resource:060ae840b34eff319ebad67cdd6a337f]Jacqueline Bernard, M.D. [clinicaltrials_resource:065c2f8b54459d2f3ad7709272014317]Andrzej Jakubowiak [clinicaltrials_resource:06b3f9067bc40352c56d87459bf56372]TARIQ MALIK, MD [clinicaltrials_resource:06f465647d62a81ee28d98bd658401c2]Scott E Eggener, MD [clinicaltrials_resource:073f26b3482d8163459756b603a53317]Silvana Pannain, MD [clinicaltrials_resource:0904557e80761827698501f5bff184f0]Harriet de Wit, Ph.D. [clinicaltrials_resource:09c96b5f857785e6e879382020c244eb]Stephen B Hanauer, MD [clinicaltrials_resource:0b0c0ddaaa1956741546866f3a5b056f]Helen Te, MD [clinicaltrials_resource:0b47ebaff8cdc1d43391278a4d4336b9]Victor Mor-Avi, Ph.D. [clinicaltrials_resource:0b60c7c43a25d879a40a177e1357c384]Joseph A Toljanic, Prof. [clinicaltrials_resource:0c2a51eee358331cb84853a9ce186cec]Siri Atma W Greeley, MD, PhD [clinicaltrials_resource:0c6edc22b52c9a7d33e4da6088cd6600]Michael Msall, M.D. [clinicaltrials_resource:0c7e7326c17e306cefbc35515a2d0eef]Robert M Naclerio, MD [clinicaltrials_resource:0c9c276ba57803fd6ef4ed51ac063af8]Jon E Grant, MD, JD, MPH [clinicaltrials_resource:0cb7b9275f2cef8ec15ce7edad4918e9]Kristen Knuston, PhD [clinicaltrials_resource:0d5ad60c5eeb0cf4955562222d79c261]Jacqueline Bernard, M.D. [clinicaltrials_resource:0d988634edc380e2332f5e9a0a49f6a3]Koen Van Besien, MD [clinicaltrials_resource:0e90c7d36b650a2b638889affa18a9fa]Robert Naclerio, M.D. [clinicaltrials_resource:0e9f547f7940c9de9222db7a2628044a]Sydney L Hans, PhD [clinicaltrials_resource:0ed3280df0b7ff906c4fd231749243c1]Chadi Nabhan [clinicaltrials_resource:0f6a78a9b1fb7568f41c98aebee6b89f]Kress P John, MD [clinicaltrials_resource:0f93d57d650e6b3f74f6365ac17956c9]Tamara Vokes, MD [clinicaltrials_resource:0f983ba9b86c5ea1cf03069e35a35a72]Stefano Guandalini, MD [clinicaltrials_resource:10fe93cf8f50edabe3717e86231a14d7]Peter H O'Donnell, MD [clinicaltrials_resource:110618c681a5d3640d809919b37541bd]Michael Msall, M.D. [clinicaltrials_resource:11113f356513f4ba840ed4a0d2873a25]Everett Vokes, M.D. [clinicaltrials_resource:111199ef6f90297def8b28cf4111cc97]Leila Gozal, MD [clinicaltrials_resource:1116a2ae76b44e68def50e3aad51949f]
affiliation [clinicaltrials_vocabulary:affiliation]
Effects of Subanesthetic Concentrations of Nitrous Oxide - 1 [clinicaltrials:NCT00000249]Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2 [clinicaltrials:NCT00000250]clinicaltrials:NCT00000251Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4 [clinicaltrials:NCT00000252]Effects of Nitrous Oxide: A Dose-Response Analysis - 5 [clinicaltrials:NCT00000253]Isoflurane at Subanesthetic Concentrations - 6 [clinicaltrials:NCT00000254]Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7 [clinicaltrials:NCT00000255]Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8 [clinicaltrials:NCT00000256]Effects of Alcohol History on Effects of Nitrous Oxide - 9 [clinicaltrials:NCT00000257]Role of Instructions in Nitrous Oxide Effects and Choice - 10 [clinicaltrials:NCT00000258]Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11 [clinicaltrials:NCT00000259]Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12 [clinicaltrials:NCT00000260]Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13 [clinicaltrials:NCT00000261]Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14 [clinicaltrials:NCT00000262]Effects of Combined Alcohol and Nitrous Oxide Intake - 15 [clinicaltrials:NCT00000263]Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16 [clinicaltrials:NCT00000264]Subjective Effects of Nitrous Oxide in Dental Patients - 17 [clinicaltrials:NCT00000265]Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer [clinicaltrials:NCT00002939]clinicaltrials:NCT00002949clinicaltrials:NCT00002951clinicaltrials:NCT00002952clinicaltrials:NCT00003192clinicaltrials:NCT00003557O6-benzylguanine Followed by Surgery in Treating Patients With Solid Tumors That Can Be Removed During Surgery [clinicaltrials:NCT00003766]clinicaltrials:NCT00003786clinicaltrials:NCT00003950clinicaltrials:NCT00004126clinicaltrials:NCT00004127clinicaltrials:NCT00004135clinicaltrials:NCT00004141clinicaltrials:NCT00004145Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma [clinicaltrials:NCT00004153]clinicaltrials:NCT00004203clinicaltrials:NCT00005032clinicaltrials:NCT00005066clinicaltrials:NCT00005086clinicaltrials:NCT00005849clinicaltrials:NCT00006002clinicaltrials:NCT00006105clinicaltrials:NCT00015964
collaborator [clinicaltrials_vocabulary:collaborator]
Effects of Subanesthetic Concentrations of Nitrous Oxide - 1 [clinicaltrials:NCT00000249]Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2 [clinicaltrials:NCT00000250]clinicaltrials:NCT00000251Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4 [clinicaltrials:NCT00000252]Effects of Nitrous Oxide: A Dose-Response Analysis - 5 [clinicaltrials:NCT00000253]Isoflurane at Subanesthetic Concentrations - 6 [clinicaltrials:NCT00000254]Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7 [clinicaltrials:NCT00000255]Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8 [clinicaltrials:NCT00000256]Effects of Alcohol History on Effects of Nitrous Oxide - 9 [clinicaltrials:NCT00000257]Role of Instructions in Nitrous Oxide Effects and Choice - 10 [clinicaltrials:NCT00000258]Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11 [clinicaltrials:NCT00000259]Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12 [clinicaltrials:NCT00000260]Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13 [clinicaltrials:NCT00000261]Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14 [clinicaltrials:NCT00000262]Effects of Combined Alcohol and Nitrous Oxide Intake - 15 [clinicaltrials:NCT00000263]Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16 [clinicaltrials:NCT00000264]Subjective Effects of Nitrous Oxide in Dental Patients - 17 [clinicaltrials:NCT00000265]Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer [clinicaltrials:NCT00002939]clinicaltrials:NCT00002949clinicaltrials:NCT00002951clinicaltrials:NCT00002952clinicaltrials:NCT00003136clinicaltrials:NCT00003192clinicaltrials:NCT00003557O6-benzylguanine Followed by Surgery in Treating Patients With Solid Tumors That Can Be Removed During Surgery [clinicaltrials:NCT00003766]clinicaltrials:NCT00003786clinicaltrials:NCT00003950clinicaltrials:NCT00004126clinicaltrials:NCT00004127clinicaltrials:NCT00004135clinicaltrials:NCT00004141clinicaltrials:NCT00004145Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma [clinicaltrials:NCT00004153]clinicaltrials:NCT00004203Leuprolide in Determining the Cause of Gonadotropin Deficiency [clinicaltrials:NCT00004426]Leuprolide in Treating Adults With Hypogonadotropism [clinicaltrials:NCT00004438]clinicaltrials:NCT00005032clinicaltrials:NCT00005066clinicaltrials:NCT00005086clinicaltrials:NCT00005849
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Fuad Baroody, MD, University of Chicago [clinicaltrials_resource:778d7029eeb538ebce56001b0d0d5ed1]Rima McLeod, MD Professor, University of Chicago [clinicaltrials_resource:7ad36a2b507ea7131db3defe66325b6f]University of Chicago [clinicaltrials_resource:a5239093f4f484869d4e5e138bd9dded]Sandeep Nathan, MD, University of Chicago [clinicaltrials_resource:d74ccbfcbcc1effe4a0c520dbe3cdc09]
organization [clinicaltrials_vocabulary:organization]
Effects of Subanesthetic Concentrations of Nitrous Oxide - 1 [clinicaltrials:NCT00000249]Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2 [clinicaltrials:NCT00000250]clinicaltrials:NCT00000251Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4 [clinicaltrials:NCT00000252]Effects of Nitrous Oxide: A Dose-Response Analysis - 5 [clinicaltrials:NCT00000253]Isoflurane at Subanesthetic Concentrations - 6 [clinicaltrials:NCT00000254]Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7 [clinicaltrials:NCT00000255]Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8 [clinicaltrials:NCT00000256]Effects of Alcohol History on Effects of Nitrous Oxide - 9 [clinicaltrials:NCT00000257]Role of Instructions in Nitrous Oxide Effects and Choice - 10 [clinicaltrials:NCT00000258]Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11 [clinicaltrials:NCT00000259]Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12 [clinicaltrials:NCT00000260]Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13 [clinicaltrials:NCT00000261]Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14 [clinicaltrials:NCT00000262]Effects of Combined Alcohol and Nitrous Oxide Intake - 15 [clinicaltrials:NCT00000263]Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16 [clinicaltrials:NCT00000264]Subjective Effects of Nitrous Oxide in Dental Patients - 17 [clinicaltrials:NCT00000265]Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer [clinicaltrials:NCT00002939]clinicaltrials:NCT00002949clinicaltrials:NCT00002951clinicaltrials:NCT00002952clinicaltrials:NCT00003136clinicaltrials:NCT00003192clinicaltrials:NCT00003557O6-benzylguanine Followed by Surgery in Treating Patients With Solid Tumors That Can Be Removed During Surgery [clinicaltrials:NCT00003766]clinicaltrials:NCT00003786clinicaltrials:NCT00003950clinicaltrials:NCT00004126clinicaltrials:NCT00004127clinicaltrials:NCT00004135clinicaltrials:NCT00004141clinicaltrials:NCT00004145Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma [clinicaltrials:NCT00004153]clinicaltrials:NCT00004203clinicaltrials:NCT00005032clinicaltrials:NCT00005066clinicaltrials:NCT00005086clinicaltrials:NCT00005849clinicaltrials:NCT00006002clinicaltrials:NCT00006105
source [clinicaltrials_vocabulary:source]
University of Chicago [clinicaltrials_resource:62f4153f5eb867c0d7e29607386bc8cd]
Bio2RDF identifier
62f4153f5eb867c0d7e29607386bc8cd
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:62f4153f5eb867c0d7e29607386bc8cd
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:62f4153f5eb867c0d7e29607386bc8cd
title
University of Chicago
@en
type
label
University of Chicago [clinicaltrials_resource:62f4153f5eb867c0d7e29607386bc8cd]
@en